In our cohort of 28 patients, Ga-68 PSMA PET/CT changed management of treatment in 7 patients by confirming presence of bone metastasis that was missed by bone scan in 3 patients or by excluding presence of metastasis that was recorded on bone scan in 4 patients. The gene discussed is FOLH1; the disease is bone metastasis.